EASTON, MA and NEW YORK, NY / ACCESSWIRE / March 10, 2015 / Pressure BioSciences Inc., ("PBI" or the "Company") (OTCQB: PBIO), a company focused on the development, marketing, and sale of proprietary laboratory instrumentation and associated consumables based on Pressure Cycling Technology ("PCT"), granted an exclusive interview at the recent FSXinterlinked Investment Conference, held in New Orleans.

Pressure BioSciences Inc., ("PBI") (OTCQB: PBIO) was one of the presenting companies at the recent FSXinterlinked Investment Conference, held at the Ritz Carlton, New Orleans.

PBI is focused on the development, marketing, and sale of proprietary laboratory instrumentation and associated consumables based on Pressure Cycling Technology ("PCT"). PCT is a patented, enabling technology platform with multiple applications in the estimated $6 billion life sciences sample preparation market. PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels to precisely and reproducibly control bio-molecular interactions.

During the event, FSXinterlinked host, Troy Vanderburg, interviewed Richard T. Schumacher, PBI's CEO.

"Troy possesses a unique industry perspective, developed through many years of capital markets experience, which enables him to ask just the right questions to get the most informative descriptions of what these companies do and who these entrepreneurs really are." stated Delray Wannemacher, FSXinterlinked President.

During the interview, Mr. Schumacher shared exciting news about the Company. Mr. Schumacher stated, "We think this is our year. We believe this is the year we cross over that threshold from being a research-based company to being a marketing and sales driven company. We have started to hire the team needed to move forward, we have already developed the unique PCT-based product line, and we believe our financial situation is better than it has been in some time. We have also started to talk in earnest with several potential strategic partners. You put all that together and we think we are going to have one great year."

The complete exclusive interview is available only on the FSXinterlinked channel on InterlinkedTV.

More information is available at PBIO's Public Profile on Interlinked.com and on their website.

About FSXinterlinked Investment Conference

FSXinterlinked is the premier investment conference organization in the United States. Founded as Financial Services Exchange (FSX) in 1983, it is one of the longest standing and most trusted investment conferences in the country for Broker Dealers and financial professionals. For more information about our organization please visit FSXinterlinked.com.

About Interlinked

Interlinked is a global investment community of investors, emerging growth companies, and resource partners. Interlinked offers an efficient way for companies to maximize exposure and access a private network of funding sources and verified service providers. For investors, Interlinked provides a secure environment to find, vet and engage companies, and communicate with members. Interlinked gives members exclusive access to a proprietary investment platform, which integrates virtual data rooms, video news, a service provider marketplace, an event directory, and customized marketing services, including email marketing, video production, public relations and more. For more information, visit: http://www.interlinked.com/.

Safe Harbor Statement

This press release may contain information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements, trends, analysis, and other information contained in this press release, including words such as "anticipate," "believe," "plan," "estimate," "expect," "intend," and other similar expressions of opinion, constitute forward-looking statements. Any such forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from any future results described within the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company's reports filed with the Securities and Exchange Commission. The forward-looking information provided herein represents the Company's estimates as of the date of the press release, and subsequent events and developments may cause the Company's estimates to change. The Company specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company's estimates of its future financial performance as of any date subsequent to the date of this press release.


SOURCE: Pressure Biosciences, Inc.